Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Short-term Investments (2020 - 2024)

Historic Short-term Investments for Cellebrite DI (CLBT) over the last 5 years, with Q4 2024 value amounting to $153.7 million.

  • Cellebrite DI's Short-term Investments rose 10578.21% to $153.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $153.7 million, marking a year-over-year increase of 10578.21%. This contributed to the annual value of $153.7 million for FY2024, which is 10578.21% up from last year.
  • Per Cellebrite DI's latest filing, its Short-term Investments stood at $153.7 million for Q4 2024, which was up 10578.21% from $74.7 million recorded in Q4 2023.
  • In the past 5 years, Cellebrite DI's Short-term Investments registered a high of $153.7 million during Q4 2024, and its lowest value of $5.1 million during Q4 2020.
  • Over the past 5 years, Cellebrite DI's median Short-term Investments value was $38.3 million (recorded in 2021), while the average stood at $46.1 million.
  • Within the past 5 years, the most significant YoY rise in Cellebrite DI's Short-term Investments was 13163.46% (2022), while the steepest drop was 4116.47% (2022).
  • Cellebrite DI's Short-term Investments (Quarter) stood at $5.1 million in 2020, then skyrocketed by 817.4% to $47.1 million in 2021, then rose by 8.93% to $51.3 million in 2022, then surged by 45.54% to $74.7 million in 2023, then surged by 105.78% to $153.7 million in 2024.
  • Its last three reported values are $153.7 million in Q4 2024, $74.7 million for Q4 2023, and $51.3 million during Q4 2022.